|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
cyclopentenone results in increased cleavage of and results in increased activity of CASP3 protein |
CTD |
PMID:18383863 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
ISO |
cyclopentenone results in increased expression of CDKN1B |
CTD |
PMID:16061222 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases phosphorylation |
ISO |
cyclopentenone results in decreased phosphorylation of RB1 protein |
CTD |
PMID:16061222 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
4-phenyl-3-furoxancarbonitrile results in increased expression of GCLC mRNA 4-phenyl-3-furoxancarbonitrile analog results in increased expression of GCLC mRNA |
CTD |
PMID:22851183 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
4-phenyl-3-furoxancarbonitrile results in increased expression of GCLM mRNA |
CTD |
PMID:22851183 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
4-phenyl-3-furoxancarbonitrile results in increased expression of NQO1 mRNA |
CTD |
PMID:22851183 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
|
G |
Acly |
ATP citrate lyase |
increases abundance |
ISO |
ACLY protein results in increased abundance of Acetyl Coenzyme A |
CTD |
PMID:28077572 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
App |
amyloid beta precursor protein |
affects localization increases secretion multiple interactions |
ISO |
APP protein affects the localization of Acetyl Coenzyme A Acetyl Coenzyme A results in increased secretion of APP protein modified form Acetyl Coenzyme A inhibits the reaction [Hydrogen Peroxide results in decreased secretion of APP protein modified form] IL1B protein affects the reaction [APP protein affects the localization of Acetyl Coenzyme A] |
CTD |
PMID:16122837 PMID:22906069 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Crat |
carnitine O-acetyltransferase |
decreases activity |
EXP |
Acetyl Coenzyme A deficiency results in decreased activity of CRAT protein |
CTD |
PMID:8075222 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
decreases abundance multiple interactions |
ISO |
ERCC6 gene mutant form results in decreased abundance of Acetyl Coenzyme A 3-Hydroxybutyric Acid inhibits the reaction [ERCC6 gene mutant form results in decreased abundance of Acetyl Coenzyme A]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [ERCC6 gene mutant form results in decreased abundance of Acetyl Coenzyme A] |
CTD |
PMID:25440059 |
|
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
IL1B protein affects the reaction [APP protein affects the localization of Acetyl Coenzyme A] |
CTD |
PMID:16122837 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Kat2b |
lysine acetyltransferase 2B |
affects binding |
ISO |
Acetyl Coenzyme A binds to KAT2B protein |
CTD |
PMID:28077572 |
|
NCBI chr 9:6,562,525...6,667,064
Ensembl chr 9:6,562,288...6,667,064
|
|
G |
Metrnl |
meteorin-like, glial cell differentiation regulator |
multiple interactions |
ISO |
METRNL protein inhibits the reaction [Dietary Fats results in decreased abundance of Acetyl Coenzyme A] |
CTD |
PMID:30213948 |
|
NCBI chr10:106,963,880...106,977,875
Ensembl chr10:106,963,880...106,977,869
|
|
G |
Nat1 |
N-acetyltransferase 1 |
multiple interactions affects binding |
ISO |
[NQO1 protein co-treated with NADP co-treated with Acetyl Coenzyme A co-treated with NAT1 protein] results in increased activity of and results in increased reduction of 3-nitrobenzanthrone; Acetyl Coenzyme A inhibits the reaction [Cyanamide results in decreased activity of NAT1 protein]; Acetyl Coenzyme A inhibits the reaction [Iodoacetamide results in decreased activity of NAT1 protein] Acetyl Coenzyme A binds to NAT1 protein |
CTD |
PMID:20545351 PMID:22835378 |
|
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Nat2 |
N-acetyltransferase 2 |
multiple interactions |
ISO |
[NAT2 protein co-treated with Acetyl Coenzyme A] promotes the reaction [[NQO1 protein co-treated with NADP] results in increased activity of and results in increased reduction of 3-nitrobenzanthrone]; [NAT2 protein co-treated with Acetyl Coenzyme A] promotes the reaction [[SULT1A2 protein co-treated with Phosphoadenosine Phosphosulfate] results in increased activity of and results in increased reduction of 3-nitrobenzanthrone] |
CTD |
PMID:20545351 |
|
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO |
[NAT2 protein co-treated with Acetyl Coenzyme A] promotes the reaction [[NQO1 protein co-treated with NADP] results in increased activity of and results in increased reduction of 3-nitrobenzanthrone]; [NQO1 protein co-treated with NADP co-treated with Acetyl Coenzyme A co-treated with NAT1 protein] results in increased activity of and results in increased reduction of 3-nitrobenzanthrone |
CTD |
PMID:20545351 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
ISO |
aurapten promotes the reaction [ABCB1 protein results in increased hydrolysis of Adenosine Triphosphate]; aurapten promotes the reaction [ABCB1 protein results in increased import of Daunorubicin] |
CTD |
PMID:18955043 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Ccna2 |
cyclin A2 |
affects expression |
ISO |
aurapten affects the expression of CCNA2 mRNA |
CTD |
PMID:23320178 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb2 |
cyclin B2 |
affects expression |
ISO |
aurapten affects the expression of CCNB2 mRNA |
CTD |
PMID:23320178 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Cdc45 |
cell division cycle 45 |
affects expression |
ISO |
aurapten affects the expression of CDC45 mRNA |
CTD |
PMID:23320178 |
|
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
affects expression |
ISO |
aurapten affects the expression of CDK1 mRNA |
CTD |
PMID:23320178 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
affects expression |
ISO |
aurapten affects the expression of CDKN2B mRNA |
CTD |
PMID:23320178 |
|
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C |
affects expression |
ISO |
aurapten affects the expression of CDKN2C mRNA |
CTD |
PMID:23320178 |
|
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
|
|
G |
Chek1 |
checkpoint kinase 1 |
affects expression |
ISO |
aurapten affects the expression of CHEK1 mRNA |
CTD |
PMID:23320178 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chek2 |
checkpoint kinase 2 |
affects expression |
ISO |
aurapten affects the expression of CHEK2 mRNA |
CTD |
PMID:23320178 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Ctnnb1 |
catenin beta 1 |
decreases expression |
EXP |
aurapten results in decreased expression of CTNNB1 protein mutant form |
CTD |
PMID:16012713 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
aurapten inhibits the reaction [DDT results in increased expression of CYP1A1 mRNA]; aurapten inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:20865247 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
affects expression |
ISO |
aurapten affects the expression of DDIT3 mRNA |
CTD |
PMID:23320178 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
affects expression |
ISO |
aurapten affects the expression of DUSP1 mRNA |
CTD |
PMID:23320178 |
|
NCBI chr10:16,680,489...16,683,276
|
|
G |
E2f1 |
E2F transcription factor 1 |
affects expression |
ISO |
aurapten affects the expression of E2F1 mRNA |
CTD |
PMID:23320178 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f2 |
E2F transcription factor 2 |
affects expression |
ISO |
aurapten affects the expression of E2F2 mRNA |
CTD |
PMID:23320178 |
|
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
affects expression |
ISO |
aurapten affects the expression of GADD45A mRNA |
CTD |
PMID:23320178 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
affects expression |
ISO |
aurapten affects the expression of JUN mRNA |
CTD |
PMID:23320178 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kif20b |
kinesin family member 20B |
affects expression |
ISO |
aurapten affects the expression of KIF20B mRNA |
CTD |
PMID:23320178 |
|
NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
affects expression |
ISO |
aurapten affects the expression of MCM3 mRNA |
CTD |
PMID:23320178 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
|
|
G |
Mcm6 |
minichromosome maintenance complex component 6 |
affects expression |
ISO |
aurapten affects the expression of MCM6 mRNA |
CTD |
PMID:23320178 |
|
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects response to substance |
ISO |
NFE2L2 protein affects the susceptibility to aurapten |
CTD |
PMID:19150646 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
aurapten inhibits the reaction [DDT results in increased expression of PTGS2 mRNA]; aurapten inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] |
CTD |
PMID:20865247 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Uhrf1 |
ubiquitin-like with PHD and ring finger domains 1 |
affects expression |
ISO |
aurapten affects the expression of UHRF1 mRNA |
CTD |
PMID:23320178 |
|
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
aurapten inhibits the reaction [DDT results in increased expression of VEGFA mRNA]; aurapten inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of VEGFA mRNA] |
CTD |
PMID:20865247 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases expression |
ISO |
bryostatin 1 results in increased expression of BIRC3 mRNA |
CTD |
PMID:14527959 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Cd22 |
CD22 molecule |
increases expression |
ISO |
bryostatin 1 results in increased expression of CD22 protein |
CTD |
PMID:10741703 |
|
NCBI chr 1:86,116,376...86,132,782
Ensembl chr 1:86,117,459...86,132,322
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions |
ISO |
bryostatin 1 inhibits the reaction [Paclitaxel results in increased activity of CDK1 protein] |
CTD |
PMID:10516758 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
F3 |
coagulation factor III, tissue factor |
increases expression |
ISO |
bryostatin 1 results in increased expression of F3 protein |
CTD |
PMID:25569083 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Il10 |
interleukin 10 |
decreases expression |
ISO |
bryostatin 1 analog results in decreased expression of IL10 mRNA; bryostatin 1 results in decreased expression of IL10 mRNA |
CTD |
PMID:15614042 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12b |
interleukin 12B |
decreases expression increases expression |
ISO |
bryostatin 1 analog results in decreased expression of IL12B mRNA bryostatin 1 results in increased expression of IL12B mRNA |
CTD |
PMID:15614042 |
|
NCBI chr10:28,888,832...28,903,796
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Itgax |
integrin subunit alpha X |
increases expression |
ISO |
bryostatin 1 results in increased expression of ITGAX protein |
CTD |
PMID:10741703 |
|
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:182,719,609...182,740,698
|
|
G |
Prkca |
protein kinase C, alpha |
multiple interactions decreases expression |
ISO |
[bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCA protein bryostatin 1 results in decreased expression of PRKCA protein |
CTD |
PMID:8892972 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prkcb |
protein kinase C, beta |
multiple interactions decreases expression |
ISO |
[bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCB protein; [bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCB protein alternative form bryostatin 1 results in decreased expression of PRKCB protein; bryostatin 1 results in decreased expression of PRKCB protein alternative form |
CTD |
PMID:8892972 |
|
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
|
|
G |
Prkcg |
protein kinase C, gamma |
multiple interactions decreases expression |
ISO |
[bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCG protein bryostatin 1 results in decreased expression of PRKCG protein |
CTD |
PMID:8892972 |
|
NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:65,832,855...65,859,384
|
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions |
ISO |
N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of ATG5 mRNA] |
CTD |
PMID:31369747 |
|
NCBI chr20:47,798,222...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Becn1 |
beclin 1 |
multiple interactions |
ISO |
N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of BECN1 mRNA]; N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of BECN1 protein] |
CTD |
PMID:31369747 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of MAP1LC3B mRNA]; N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of MAP1LC3B protein] |
CTD |
PMID:31369747 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
ISO |
N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in increased expression of SQSTM1 mRNA]; N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in increased expression of SQSTM1 protein] |
CTD |
PMID:31369747 |
|
NCBI chr10:34,525,517...34,536,685
Ensembl chr10:34,525,519...34,536,673
|
|
|
G |
Nanog |
Nanog homeobox |
decreases expression |
ISO |
Chir 98014 results in decreased expression of NANOG mRNA |
CTD |
PMID:22723015 |
|
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
|
|
G |
Otx2 |
orthodenticle homeobox 2 |
decreases expression |
ISO |
Chir 98014 results in decreased expression of OTX2 mRNA |
CTD |
PMID:22723015 |
|
NCBI chr15:21,942,233...21,953,034
Ensembl chr15:21,943,191...21,953,416
|
|
G |
Pax6 |
paired box 6 |
decreases expression |
ISO |
Chir 98014 results in decreased expression of PAX6 mRNA |
CTD |
PMID:22723015 |
|
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
|
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
multiple interactions |
ISO EXP |
[BAY 58-2667 co-treated with 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one] results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]; BAY 58-2667 results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]; dicyanocobinamide promotes the reaction [BAY 58-2667 results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]] 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one promotes the reaction [BAY 58-2667 results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]; BAY 58-2667 inhibits the reaction [1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one results in increased degradation of GUCY1A1 protein]; BAY 58-2667 inhibits the reaction [Heme deficiency results in decreased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]; BAY 58-2667 results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]; zinc protoporphyrin inhibits the reaction [BAY 58-2667 inhibits the reaction [Heme deficiency results in decreased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]] |
CTD |
PMID:19466990 PMID:22171090 |
|
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
|
|
G |
Gucy1b1 |
guanylate cyclase 1 soluble subunit beta 1 |
multiple interactions affects binding |
EXP ISO |
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one promotes the reaction [BAY 58-2667 results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]; 5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide inhibits the reaction [BAY 58-2667 binds to GUCY1B1 protein]; BAY 58-2667 inhibits the reaction [Heme deficiency results in decreased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]; BAY 58-2667 results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]; zinc protoporphyrin inhibits the reaction [BAY 58-2667 binds to GUCY1B1 protein]; zinc protoporphyrin inhibits the reaction [BAY 58-2667 inhibits the reaction [Heme deficiency results in decreased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]] [BAY 58-2667 co-treated with 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one] results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]; BAY 58-2667 results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]; dicyanocobinamide promotes the reaction [BAY 58-2667 results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]] |
CTD |
PMID:19466990 PMID:22171090 |
|
NCBI chr 2:167,348,824...167,398,983
Ensembl chr 2:167,348,825...167,398,916
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
BAY 58-2667 inhibits the reaction [Isoproterenol results in increased expression of PTGS2 mRNA] |
CTD |
PMID:19667237 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
BAY 58-2667 inhibits the reaction [Isoproterenol results in increased expression of TGFB1 mRNA] |
CTD |
PMID:19667237 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
|
G |
Il13 |
interleukin 13 |
decreases expression decreases secretion |
ISO |
Etazolate results in decreased expression of IL13 mRNA Etazolate results in decreased secretion of IL13 protein |
CTD |
PMID:16083514 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Ltc4s |
leukotriene C4 synthase |
decreases secretion |
ISO |
Etazolate results in decreased secretion of LTC4S protein |
CTD |
PMID:16083514 |
|
NCBI chr10:34,560,476...34,562,790
Ensembl chr10:34,560,360...34,562,651
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression multiple interactions |
ISO |
Ethoxyquin results in increased expression of ABCC2 mRNA [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC2 mRNA |
CTD |
PMID:15833929 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression multiple interactions |
ISO |
Ethoxyquin results in increased expression of ABCC3 mRNA [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC3 mRNA |
CTD |
PMID:15833929 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
increases expression multiple interactions |
ISO |
Ethoxyquin results in increased expression of ABCC4 mRNA [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC4 mRNA |
CTD |
PMID:15833929 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
multiple interactions increases expression |
ISO |
[Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC5 mRNA Ethoxyquin results in increased expression of ABCC5 mRNA |
CTD |
PMID:15833929 |
|
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
increases expression multiple interactions |
ISO |
Ethoxyquin results in increased expression of ABCC6 mRNA [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC6 mRNA |
CTD |
PMID:15833929 |
|
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression multiple interactions |
ISO |
Ethoxyquin results in increased expression of AKR1B10 mRNA NFE2L2 protein promotes the reaction [Ethoxyquin results in increased expression of AKR1B10 mRNA] |
CTD |
PMID:21277289 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
increases activity increases expression |
EXP |
Ethoxyquin results in increased activity of AKR7A3 protein Ethoxyquin results in increased expression of AKR7A3 mRNA; Ethoxyquin results in increased expression of AKR7A3 protein |
CTD |
PMID:8198522 PMID:8395332 PMID:9328168 PMID:19695238 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
ISO EXP |
Ethoxyquin results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:17998271 PMID:19695238 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
increases expression |
ISO |
Ethoxyquin results in increased expression of ALDH1B1 mRNA |
CTD |
PMID:17998271 |
|
NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
decreases activity |
EXP |
Ethoxyquin results in decreased activity of ALOX5 protein |
CTD |
PMID:3928952 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Dihydrotestosterone inhibits the reaction [Ethoxyquin results in increased activity of AR protein]; Ethoxyquin inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA] |
CTD |
PMID:15064155 PMID:21310686 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Ces2c |
carboxylesterase 2C |
increases expression |
ISO |
Ethoxyquin results in increased expression of CES2C mRNA |
CTD |
PMID:22429928 |
|
NCBI chr 1:260,391,190...260,398,757
Ensembl chr 1:260,388,902...260,398,790
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases activity increases expression |
EXP |
Ethoxyquin inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein] Ethoxyquin results in increased activity of CYP1A1 protein Ethoxyquin results in increased expression of CYP1A1 mRNA |
CTD |
PMID:16906435 PMID:19695238 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
EXP |
Ethoxyquin results in increased expression of CYP1A2 mRNA |
CTD |
PMID:19695238 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
EXP |
Ethoxyquin results in increased expression of CYP1B1 mRNA |
CTD |
PMID:19695238 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression |
ISO |
Ethoxyquin results in increased expression of CYP2B10 mRNA |
CTD |
PMID:17627975 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b15 |
cytochrome P450, family 2, subfamily b, polypeptide 15 |
increases expression |
EXP |
Ethoxyquin results in increased expression of CYP2B15 mRNA |
CTD |
PMID:19695238 |
|
NCBI chr 1:82,094,188...82,106,492
Ensembl chr 1:82,094,180...82,106,492
|
|
G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
increases expression |
EXP |
Ethoxyquin results in increased expression of CYP3A18 mRNA |
CTD |
PMID:19695238 |
|
NCBI chr12:8,880,528...8,930,382
Ensembl chr12:8,880,528...8,930,381
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases expression |
EXP |
Ethoxyquin results in increased expression of CYP3A23-3A1 mRNA |
CTD |
PMID:19695238 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
EXP |
Ethoxyquin results in increased expression of EPHX1 mRNA |
CTD |
PMID:19695238 |
|
NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression |
ISO EXP |
Ethoxyquin results in increased expression of GSTA2 protein Ethoxyquin results in increased expression of GSTA2 mRNA |
CTD |
PMID:11309284 PMID:19695238 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
increases expression |
ISO EXP |
Ethoxyquin results in increased expression of GSTA3 protein |
CTD |
PMID:8198522 PMID:9794803 PMID:11309284 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
increases expression |
EXP |
Ethoxyquin results in increased expression of GSTA4 mRNA; Ethoxyquin results in increased expression of GSTA4 protein |
CTD |
PMID:9794803 PMID:19695238 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
multiple interactions increases expression increases activity |
EXP ISO |
Ethoxyquin promotes the reaction [GSTA5 protein affects the metabolism of aflatoxin B1-2,3-oxide]; Ethoxyquin results in increased expression of and results in increased activity of GSTA5 protein Ethoxyquin results in increased expression of GSTA1 protein Ethoxyquin results in increased expression of GSTA5 mRNA; Ethoxyquin results in increased expression of GSTA5 protein Ethoxyquin results in increased activity of GSTA5 protein |
CTD |
PMID:1637297 PMID:8198522 PMID:9328168 PMID:9794803 PMID:11309284 PMID:19695238 More...
|
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gsta6 |
glutathione S-transferase alpha 6 |
increases expression |
ISO |
Ethoxyquin results in increased expression of GSTA2 protein |
CTD |
PMID:11309284 |
|
NCBI chr 9:23,743,262...23,806,260
Ensembl chr 9:23,744,288...23,801,131
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression |
ISO EXP |
Ethoxyquin results in increased expression of GSTM1 mRNA; Ethoxyquin results in increased expression of GSTM1 protein |
CTD |
PMID:8198522 PMID:11309284 PMID:18723825 PMID:19695238 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
increases expression |
EXP ISO |
Ethoxyquin results in increased expression of GSTM2 mRNA |
CTD |
PMID:18723825 PMID:19695238 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
increases expression |
ISO |
Ethoxyquin results in increased expression of GSTM4 mRNA |
CTD |
PMID:18723825 |
|
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
increases expression |
ISO EXP |
Ethoxyquin results in increased expression of GSTM3 mRNA; Ethoxyquin results in increased expression of GSTM5 protein Ethoxyquin results in increased expression of GSTM3 protein |
CTD |
PMID:9794803 PMID:11309284 PMID:18723825 |
|
NCBI chr 2:195,531,627...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
EXP |
Ethoxyquin results in increased expression of GSTP1 mRNA; Ethoxyquin results in increased expression of GSTP1 protein |
CTD |
PMID:8198522 PMID:9794803 PMID:19695238 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases expression |
ISO EXP |
Ethoxyquin results in increased expression of GSTT1 mRNA Ethoxyquin results in increased expression of GSTT1 mRNA; Ethoxyquin results in increased expression of GSTT1 protein |
CTD |
PMID:9794803 PMID:18723825 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Ethoxyquin results in increased expression of HMOX1 mRNA; Ethoxyquin results in increased expression of HMOX1 protein |
CTD |
PMID:25690736 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
[Ethoxyquin results in increased expression of PRDX1 protein] which results in increased phosphorylation of MAPK14 protein |
CTD |
PMID:16880205 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
increases expression |
ISO |
Ethoxyquin results in increased expression of MGST1 mRNA |
CTD |
PMID:18723825 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Mgst3 |
microsomal glutathione S-transferase 3 |
increases expression |
ISO |
Ethoxyquin results in increased expression of MGST3 mRNA |
CTD |
PMID:18723825 |
|
NCBI chr13:79,526,541...79,547,479
Ensembl chr13:79,526,541...79,547,411
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions affects activity |
ISO |
NFE2L2 protein promotes the reaction [Ethoxyquin results in increased expression of AKR1B10 mRNA] Ethoxyquin affects the activity of NFE2L2 protein [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC2 mRNA; [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC3 mRNA; [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC4 mRNA; [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC5 mRNA; [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC6 mRNA; Ethoxyquin binds to and results in increased activity of NFE2L2 protein |
CTD |
PMID:11309284 PMID:15833929 PMID:15919853 PMID:21277289 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nox4 |
NADPH oxidase 4 |
increases expression |
EXP |
Ethoxyquin results in increased expression of NOX4 mRNA |
CTD |
PMID:19695238 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression multiple interactions increases activity |
ISO EXP |
Ethoxyquin results in increased expression of NQO1 mRNA; Ethoxyquin results in increased expression of NQO1 protein Ethoxyquin promotes the reaction [Methylcholanthrene results in increased activity of NQO1 protein]; Methylcholanthrene promotes the reaction [Ethoxyquin results in increased activity of NQO1 protein] |
CTD |
PMID:11309284 PMID:15919853 PMID:16045903 PMID:16906435 PMID:17627975 PMID:19144771 PMID:19695238 More...
|
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions increases activity |
ISO |
Ethoxyquin binds to and results in increased activity of NR1I2 protein Ethoxyquin results in increased activity of NR1I2 protein |
CTD |
PMID:21115097 PMID:25455453 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Prdx1 |
peroxiredoxin 1 |
increases expression multiple interactions |
ISO |
Ethoxyquin results in increased expression of PRDX1 protein [Ethoxyquin results in increased expression of PRDX1 protein] which results in increased phosphorylation of MAPK14 protein |
CTD |
PMID:16880205 |
|
NCBI chr 5:130,147,276...130,162,850
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Slco2b1 |
solute carrier organic anion transporter family, member 2b1 |
increases expression |
ISO |
Ethoxyquin results in increased expression of SLCO2B1 mRNA |
CTD |
PMID:15919853 |
|
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases expression |
EXP ISO |
Ethoxyquin results in increased expression of UGT1A1 mRNA |
CTD |
PMID:19144771 PMID:19695238 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a5 |
UDP glucuronosyltransferase family 1 member A5 |
increases expression |
ISO |
Ethoxyquin results in increased expression of UGT1A5 mRNA |
CTD |
PMID:19144771 |
|
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
decreases expression |
EXP |
GSK2181236A decreases expression of Acta1 mRNA in rat myocardium |
RGD |
PMID:22783192 |
RGD:25824851 |
NCBI chr19:51,883,713...51,886,725
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Nppa |
natriuretic peptide A |
decreases expression |
EXP |
GSK2181236A decreases expression of Nppa mRNA in rat myocardium |
RGD |
PMID:22783192 |
RGD:25824851 |
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases metabolic processing |
ISO |
CYP1A1 protein results in increased metabolism of riociguat |
CTD |
PMID:30950278 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Kcnk3 |
potassium two pore domain channel subfamily K member 3 |
decreases response to substance increases activity |
ISO |
KCNK3 protein mutant form results in decreased susceptibility to riociguat riociguat results in increased activity of KCNK3 protein |
CTD |
PMID:30365877 |
|
NCBI chr 6:25,761,487...25,799,153
Ensembl chr 6:25,763,228...25,799,153
|
|
|
G |
Ctnnb1 |
catenin beta 1 |
affects localization |
ISO |
sporidesmin affects the localization of CTNNB1 protein |
CTD |
PMID:28193462 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
affects expression |
ISO |
sporidesmin affects the expression of CYP1A2 mRNA |
CTD |
PMID:28193462 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2c24 |
cytochrome P450, family 2, subfamily c, polypeptide 24 |
multiple interactions increases expression |
ISO |
MIR21 mRNA affects the reaction [sporidesmin results in increased expression of CYP2C18 mRNA]; MIR31 mRNA affects the reaction [sporidesmin results in increased expression of CYP2C18 mRNA] sporidesmin results in increased expression of CYP2C18 mRNA; sporidesmin results in increased expression of CYP2C18 protein |
CTD |
PMID:28193462 |
|
NCBI chr 1:236,873,967...236,936,238
Ensembl chr 1:236,873,967...236,936,238
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
affects expression multiple interactions |
ISO |
sporidesmin affects the expression of CYP2C8 mRNA MIR21 mRNA affects the reaction [sporidesmin affects the expression of CYP2C8 mRNA] |
CTD |
PMID:28193462 |
|
|
|
G |
Dkk3 |
dickkopf WNT signaling pathway inhibitor 3 |
decreases expression |
ISO |
sporidesmin results in decreased expression of DKK3 mRNA |
CTD |
PMID:28193462 |
|
NCBI chr 1:166,237,969...166,281,271
Ensembl chr 1:166,238,238...166,280,590
|
|
G |
Mir132 |
microRNA 132 |
increases expression |
ISO |
sporidesmin results in increased expression of MIR132 mRNA |
CTD |
PMID:28193462 |
|
NCBI chr10:60,023,696...60,023,796
Ensembl chr10:60,023,696...60,023,796
|
|
G |
Mir138-2 |
microRNA 138-2 |
increases expression |
ISO |
sporidesmin results in increased expression of MIR138-2 mRNA alternative form |
CTD |
PMID:28193462 |
|
NCBI chr19:10,674,193...10,674,274
Ensembl chr19:10,674,193...10,674,274
|
|
G |
Mir139 |
microRNA 139 |
increases expression |
ISO |
sporidesmin results in increased expression of MIR139 mRNA |
CTD |
PMID:28193462 |
|
NCBI chr 1:155,878,828...155,878,895
Ensembl chr 1:155,878,825...155,878,902
|
|
G |
Mir150 |
microRNA 150 |
increases expression |
ISO |
sporidesmin results in increased expression of MIR150 mRNA |
CTD |
PMID:28193462 |
|
NCBI chr 1:95,605,024...95,605,108
Ensembl chr 1:95,605,024...95,605,108
|
|
G |
Mir184 |
microRNA 184 |
increases expression |
ISO |
sporidesmin results in increased expression of MIR184 mRNA |
CTD |
PMID:28193462 |
|
NCBI chr 8:90,343,134...90,343,210
Ensembl chr 8:90,343,134...90,343,210
|
|
G |
Mir21 |
microRNA 21 |
increases expression multiple interactions |
ISO |
sporidesmin results in increased expression of MIR21 mRNA MIR21 mRNA affects the reaction [sporidesmin affects the expression of CYP2C8 mRNA]; MIR21 mRNA affects the reaction [sporidesmin results in increased expression of CYP2C18 mRNA] |
CTD |
PMID:28193462 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir290 |
microRNA 290 |
increases expression |
ISO |
sporidesmin results in increased expression of MIR371A mRNA |
CTD |
PMID:28193462 |
|
NCBI chr 1:65,964,648...65,964,728
Ensembl chr 1:65,964,648...65,964,728
|
|
G |
Mir295-1 |
microRNA 295-1 |
increases expression |
ISO |
sporidesmin results in increased expression of MIR372 mRNA |
CTD |
PMID:28193462 |
|
NCBI chr 1:65,962,566...65,962,646
Ensembl chr 1:65,962,566...65,962,646
|
|
G |
Mir31 |
microRNA 31 |
multiple interactions increases expression |
ISO |
MIR31 mRNA affects the reaction [sporidesmin affects the expression of WIF1 mRNA]; MIR31 mRNA affects the reaction [sporidesmin results in decreased expression of SFRP1 mRNA]; MIR31 mRNA affects the reaction [sporidesmin results in increased expression of CYP2C18 mRNA] sporidesmin results in increased expression of MIR31 mRNA |
CTD |
PMID:28193462 |
|
NCBI chr 5:103,599,038...103,599,143
|
|
G |
Mir375 |
microRNA 375 |
increases expression |
ISO |
sporidesmin results in increased expression of MIR375 mRNA |
CTD |
PMID:28193462 |
|
NCBI chr 9:76,457,911...76,457,985
Ensembl chr 9:76,457,911...76,457,985
|
|
G |
Mir409 |
microRNA 409 |
increases expression |
ISO |
sporidesmin results in increased expression of MIR409 mRNA |
CTD |
PMID:28193462 |
|
NCBI chr 6:128,757,780...128,757,856
Ensembl chr 6:128,757,779...128,757,858
|
|
G |
Mir487b |
microRNA 487b |
increases expression |
ISO |
sporidesmin results in increased expression of MIR487B mRNA |
CTD |
PMID:28193462 |
|
NCBI chr 6:128,741,485...128,741,566
Ensembl chr 6:128,741,485...128,741,566
|
|
G |
Sfrp1 |
secreted frizzled-related protein 1 |
decreases expression multiple interactions |
ISO |
sporidesmin results in decreased expression of SFRP1 mRNA MIR31 mRNA affects the reaction [sporidesmin results in decreased expression of SFRP1 mRNA] |
CTD |
PMID:28193462 |
|
NCBI chr16:68,575,763...68,613,905
Ensembl chr16:68,575,763...68,614,286
|
|
G |
Wif1 |
Wnt inhibitory factor 1 |
multiple interactions affects expression |
ISO |
MIR31 mRNA affects the reaction [sporidesmin affects the expression of WIF1 mRNA] |
CTD |
PMID:28193462 |
|
NCBI chr 7:56,548,058...56,618,364
Ensembl chr 7:56,548,053...56,618,360
|
|
|
G |
Dlg1 |
discs large MAGUK scaffold protein 1 |
increases expression multiple interactions |
ISO |
geranylgeranylacetone results in increased expression of DLG1 mRNA; geranylgeranylacetone results in increased expression of DLG1 protein geranylgeranylacetone promotes the reaction [[HSF1 protein binds to DLG1 promoter] which results in increased expression of DLG1 mRNA]; Niacinamide inhibits the reaction [geranylgeranylacetone results in increased expression of DLG1 mRNA]; resveratrol promotes the reaction [geranylgeranylacetone results in increased expression of DLG1 mRNA] |
CTD |
PMID:21232033 |
|
NCBI chr11:68,911,883...69,103,230
Ensembl chr11:68,911,883...69,102,689
|
|
G |
Edn1 |
endothelin 1 |
decreases expression |
EXP |
geranylgeranylacetone results in decreased expression of EDN1 protein |
CTD |
PMID:16324314 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
multiple interactions affects response to substance increases expression |
ISO |
geranylgeranylacetone promotes the reaction [[HSF1 protein binds to DLG1 promoter] which results in increased expression of DLG1 mRNA] HSF1 protein affects the susceptibility to geranylgeranylacetone geranylgeranylacetone results in increased expression of HSF1 protein |
CTD |
PMID:17189318 PMID:21232033 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
multiple interactions |
ISO |
geranylgeranylacetone promotes the reaction [Ethanol results in increased expression of HSPA1A protein] |
CTD |
PMID:17189318 |
|
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
multiple interactions |
ISO |
[Tetrachlorodibenzodioxin co-treated with geranylgeranylacetone] results in increased expression of HSPA1B mRNA; [Tetrachlorodibenzodioxin co-treated with geranylgeranylacetone] results in increased expression of HSPA1B protein |
CTD |
PMID:15340226 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240
|
|
G |
Kcna5 |
potassium voltage-gated channel subfamily A member 5 |
increases expression |
ISO |
geranylgeranylacetone results in increased expression of KCNA5 protein |
CTD |
PMID:21232033 |
|
NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:159,350,097...159,357,697
|
|